Variant report
Variant | nsv968142 |
---|---|
Chromosome Location | chr5:17486305-17487006 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:17486902-17487265 | Hela-S3 | cervix: | n/a | n/a |
2 | CTCF | chr5:17486619-17486669 | Fibrobl | skin: | n/a | n/a |
3 | POLR2A | chr5:17486556-17486745 | A549 | lung: | n/a | n/a |
4 | POLR2A | chr5:17486712-17486833 | MCF-7 | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251304 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7709055 | chr5:17486311-17486312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149735594 | chr5:17486312-17486313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72740571 | chr5:17486394-17486395 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542786074 | chr5:17486405-17486406 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559585391 | chr5:17486447-17486448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186941323 | chr5:17486486-17486487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551568137 | chr5:17486517-17486518 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571423440 | chr5:17486518-17486519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530837376 | chr5:17486521-17486522 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550657562 | chr5:17486554-17486555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567359871 | chr5:17486556-17486557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536342293 | chr5:17486564-17486565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553076397 | chr5:17486569-17486570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566710455 | chr5:17486575-17486576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538825781 | chr5:17486582-17486583 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113739801 | chr5:17486587-17486588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575801755 | chr5:17486602-17486603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577106190 | chr5:17486615-17486616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544899718 | chr5:17486627-17486628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556675506 | chr5:17486633-17486634 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184333451 | chr5:17486637-17486638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148889903 | chr5:17486650-17486651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186652850 | chr5:17486664-17486665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191046548 | chr5:17486669-17486670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528216140 | chr5:17486719-17486720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544828833 | chr5:17486734-17486735 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs78301965 | chr5:17486737-17486738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565095819 | chr5:17486740-17486741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183777913 | chr5:17486744-17486745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112235265 | chr5:17486752-17486753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs78984736 | chr5:17486753-17486754 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76417696 | chr5:17486754-17486755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77985297 | chr5:17486755-17486756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76097656 | chr5:17486779-17486780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs61748308 | chr5:17486783-17486784 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs61748309 | chr5:17486788-17486789 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs201910172 | chr5:17486824-17486825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546606995 | chr5:17486839-17486840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200505938 | chr5:17486841-17486842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541830986 | chr5:17486847-17486848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191192792 | chr5:17486848-17486849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552455649 | chr5:17486879-17486880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569475891 | chr5:17486880-17486881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538155264 | chr5:17486900-17486901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555330932 | chr5:17486952-17486953 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575225484 | chr5:17486977-17486978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 21364760 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Melanoma | 22183965 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 19287141 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:17483000-17487000 | Weak transcription | A549 | lung |
2 | chr5:17486200-17487800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr5:17487000-17487600 | Enhancers | A549 | lung |